Alesi Surgical

Executive Summary

Alesi Surgical is a UK-based medical device company developing the Ultravision system, a technology that actively eliminates surgical smoke during laparoscopic and open surgery using electrostatic precipitation. Surgical smoke, generated by electrosurgical tools, impairs visualization and exposes operating room staff to harmful particulate matter and carcinogens. The Ultravision system addresses a clear unmet need by improving visibility for surgeons, protecting staff from smoke inhalation, and reducing patient carbon dioxide exposure. Founded in 2019, the company is privately held and has not disclosed funding or revenue. Given the increasing regulatory and safety focus on surgical smoke evacuation, Alesi Surgical is well-positioned to capture market share in both the US and Europe. The company's competitive advantage lies in its active, real-time smoke removal technology, which differentiates it from passive filters or manual evacuation. With a growing body of clinical evidence and upcoming regulatory milestones, Alesi Surgical has the potential to become a standard in operating rooms globally. However, as a private early-stage firm, it faces challenges in commercial scaling and securing distribution partnerships.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for Ultravision system70% success
• Q3 2026Publication of pivotal clinical trial results60% success
• Q2 2026Strategic distribution partnership in the US or Europe50% success